Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:HEMA NASDAQ:OTRK NASDAQ:VMD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHEMAHemaCare$25.31+0.6%$25.31$8.62▼$26.23$346.52M1.4739,950 shs5,400 shsOTRKOntrak$0.02-24.9%$0.03$0.05▼$1.78$93K1.972.80 million shs12,218 shsVMDViemed Healthcare$9.63$9.46$5.93▼$10.18$369.79M1.15251,501 shs60,437 shsBeginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHEMAHemaCare0.00%0.00%0.00%0.00%0.00%OTRKOntrak0.00%0.00%0.00%0.00%-98.59%VMDViemed Healthcare-0.52%+1.48%+4.00%+16.87%+44.38%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHEMAHemaCare$25.31+0.6%$25.31$8.62▼$26.23$346.52M1.4739,950 shs5,400 shsOTRKOntrak$0.02-24.9%$0.03$0.05▼$1.78$93K1.972.80 million shs12,218 shsVMDViemed Healthcare$9.63$9.46$5.93▼$10.18$369.79M1.15251,501 shs60,437 shsBeginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHEMAHemaCare0.00%0.00%0.00%0.00%0.00%OTRKOntrak0.00%0.00%0.00%0.00%-98.59%VMDViemed Healthcare-0.52%+1.48%+4.00%+16.87%+44.38%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHEMAHemaCare 0.00N/AN/AN/AOTRKOntrak 3.00Buy$3.0013,536.36% UpsideVMDViemed Healthcare 2.00HoldN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHEMAHemaCareN/AN/AN/AN/AN/AN/AOTRKOntrak$10.18M0.01N/AN/A$2.34 per share0.01VMDViemed Healthcare$270.28M1.37$1.15 per share8.41$3.80 per share2.54Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHEMAHemaCareN/AN/AN/AN/AN/AN/AN/AN/AN/AOTRKOntrak-$25.49M-$15.81N/AN/AN/A-274.20%-269.88%-128.35%N/AVMDViemed Healthcare$14.93M$0.3726.0816.65N/A5.20%10.52%7.60%8/5/2026 (Estimated)Latest OTRK, VMD, and HEMA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/5/2026Q1 2026VMDViemed Healthcare$0.09$0.06-$0.03$0.06$74.40 million$75.41 million3/4/2026Q4 2025VMDViemed Healthcare$0.12$0.14+$0.02$0.14$77.70 million$76.18 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthHEMAHemaCareN/AN/AN/AN/AN/AOTRKOntrakN/AN/AN/AN/AN/AVMDViemed HealthcareN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHEMAHemaCareN/AN/AN/AOTRKOntrak0.540.720.72VMDViemed Healthcare0.061.221.10Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHEMAHemaCareN/AOTRKOntrak12.95%VMDViemed Healthcare74.24%Insider OwnershipCompanyInsider OwnershipHEMAHemaCare26.20%OTRKOntrak1.90%VMDViemed Healthcare20.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHEMAHemaCareN/A13.69 millionN/ANot OptionableOTRKOntrak2504.22 million4.14 millionNo DataVMDViemed Healthcare1,38238.34 million30.67 millionNot OptionableOTRK, VMD, and HEMA HeadlinesRecent News About These CompaniesStonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (VMD) 1Q26May 12, 2026 | newsfilecorp.comNViemed Healthcare Q1 Earnings Call HighlightsMay 7, 2026 | marketbeat.comViemed Healthcare, Inc. (VMD) Q1 2026 Earnings Call TranscriptMay 6, 2026 | seekingalpha.comViemed (VMD) Q1 2026 Earnings TranscriptMay 6, 2026 | fool.comViemed Healthcare, Inc. (VMD) Q1 Earnings Miss EstimatesMay 5, 2026 | zacks.comViemed Healthcare (NASDAQ:VMD) Posts Quarterly Earnings Results, Misses Expectations By $0.03 EPSMay 5, 2026 | marketbeat.comViemed Healthcare Announces First Quarter 2026 Financial ResultsMay 5, 2026 | accessnewswire.comAViemed Healthcare (VMD) to Release Quarterly Earnings on TuesdayApril 28, 2026 | marketbeat.comViemed Healthcare Announces First Quarter 2026 Earnings Conference Call DetailsApril 21, 2026 | accessnewswire.comAViemed Healthcare (NASDAQ:VMD) President Sells $297,389.40 in StockMarch 21, 2026 | insidertrades.comViemed Healthcare to Present at Sidoti's Small-Cap Virtual Investor Conference March 18-19March 16, 2026 | accessnewswire.comAStonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (VMD) 4Q 2025March 11, 2026 | newsfilecorp.comNViemed Healthcare, Inc. (NASDAQ:VMD) Q4 2025 earnings call transcriptMarch 6, 2026 | msn.comViemed Healthcare, Inc. (VMD) Q4 2025 Earnings Call TranscriptMarch 5, 2026 | seekingalpha.comViemed Healthcare Announces 2026 Share Repurchase ProgramMarch 4, 2026 | accessnewswire.comAViemed Healthcare Announces Record 2025 Financial ResultsMarch 4, 2026 | accessnewswire.comAViemed Healthcare Announces Year End 2025 Earnings Conference Call DetailsFebruary 24, 2026 | accessnewswire.comAStonegate Capital Partners Initiates Coverage on Viemed Healthcare, Inc. (VMD)January 6, 2026 | newsfilecorp.comNViemed Healthcare, Inc. (VMD) Q3 2025 Earnings Call TranscriptNovember 7, 2025 | seekingalpha.comViemed Healthcare Inc (VMD) Q3 2025 Earnings Call Highlights: Record Revenue Growth and ...November 7, 2025 | finance.yahoo.comViemed Healthcare Announces Third Quarter 2025 Financial ResultsNovember 5, 2025 | accessnewswire.comANew MarketBeat Followers Over TimeMedia Sentiment Over TimeOTRK, VMD, and HEMA Company DescriptionsHemaCare OTCMKTS:HEMA$25.31 +0.15 (+0.60%) As of 01/3/2020HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy. It offers human blood cellular components derived from peripheral blood, bone marrow, and cord blood; and a range of consulting services in standard operating procedure development, personnel training, and quality and regulatory compliance. The company's network of FDA-registered, GMP/GTP-compliant collection centers ensures donor materials available to customers, as well as for use within its isolation laboratory. The company has strategic partnership with Charles River Laboratories International Inc. for human immune system research. HemaCare Corporation was founded in 1978 and is headquartered in Northridge, California.Ontrak NASDAQ:OTRKOntrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need. The company's technology enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators, who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. Ontrak, Inc. was incorporated in 2003 and is headquartered in Miami, Florida.Viemed Healthcare NASDAQ:VMD$9.63 0.00 (0.00%) As of 12:42 PM Eastern This is a fair market value price provided by Massive. Learn more.Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending Intuit's Great SaaS Reset: Fired By AI Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish Target Shows Strengths, But Analysts Want to See More Lowe's Finds Support at $215 After Q1 Earnings Sell-Off Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
